New appointment at Catalyst Biosciences
05 March 2010
Zoe Dann
Please Login to read the full article.
05 March 2010
Zoe Dann
zoe.dann@informa.com
Catalyst Biosciences, a US company focused on the discovery and development of engineered proteases known as Alterase therapeutics, has named
William Dawson chief financial officer. He has more than 30 years' financial management and business development experience, having previously served as...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Quintiles invests in biomarker start-up; Glyn Edwards to head
- Alkermes' PhII ALKS-5461: new mechanism, opiate receptor modulation, for refractory depression
- ImmusanT start-up raises $20m to advance therapeutic vaccine for coeliac disease
- Stem cell death for cash-crunched Geron, Angiotech, but Mesoblast outlasts them
FEATURES
- DKSH highlights one-stop benefits as it builds Asia market expansion services
- Merck BioVentures: where biosimilars make a difference
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
